XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Mar. 31, 2024
Jun. 30, 2024
Jun. 30, 2023
Shares      
Shares, Outstanding, Beginning Balance (in shares) 12,223,637 12,223,637  
Shares, Granted (in shares)   1,903,482  
Shares, Exercised (in shares)   (330,641)  
Shares, Forfeited or expired (in shares)   (119,105)  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period   (171,485)  
Shares, Outstanding, Ending Balance (in shares)   13,505,888  
Shares, Exercisable (in shares)   8,404,002  
Shares, Vested and expected to vest (in shares)   12,415,387  
Weighted- Average Exercise Price      
Weighted- Average Exercise Price, Outstanding, Beginning Balance (in dollars per share) $ 15.11 $ 15.11  
Weighted- Average Exercise Price, Granted (in dollars per share)   16.45  
Weighted- Average Exercise Price, Exercised (in dollars per share)   9.43  
Weighted- Average Exercise Price, Forfeited (in dollars per share)   11.80  
Weighted- Average Exercise Price, Expired (in dollars per share)   22.83  
Weighted- Average Exercise Price, Outstanding, Ending Balance (in dollars per share)   15.37  
Weighted- Average Exercise Price, Exercisable (in dollars per share)   18.11  
Weighted- Average Exercise Price, Vested and expected to vest (in dollars per share)   $ 15.78  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Weighted- Average Remaining Contractual Term, Outstanding (in years) 6 years 8 months 12 days 6 years 8 months 12 days  
Weighted- Average Remaining Contractual Term, Exercisable (in years)   5 years 4 months 24 days  
Weighted- Average Remaining Contractual Term, Vested and expected to vest (in years)   6 years 6 months  
Aggregate Intrinsic Value, Outstanding, Ending Balance   $ 160  
Aggregate Intrinsic Value, Exercisable   111  
Aggregate Intrinsic Value, Vested and expected to vest   $ 148  
Weighted-average grant-date fair value of options granted (in dollars per share)   $ 12.99 $ 3.78
Intrinsic value of options exercised   $ 2,615 $ 56
Fair value of shares vested   7,344 $ 3,533
Unrecognized compensation expense related to non-vested stock-options, net of related forfeiture estimates   $ 30,100  
Unrecognized compensation expense recognition period (in years)   1 year 6 months  
Stock Option Additional Information [Table]   The following table summarizes additional information on stock options (in thousands, except per share amounts):
Six Months Ended June 30,
20242023
Weighted-average fair value per share of stock options granted
$12.99 $3.78 
Total intrinsic value of stock options exercised
$2,615 $56 
Total cash received for stock options exercised
$3,117 $36 
Total grant date fair value of stock options vested
$7,344 $3,533